Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based

Wei Zhang1, Jibin Li, Samantha M Allen

  • 1Absorption Systems, LP, 436 Creamery Way, Suite 600, Exton, PA 19341, USA.

Insights

Stable knockdown cell lines for breast cancer resistance protein (BCRP) were created using shRNA in Caco-2 cells. These engineered cells, particularly clone D, are valuable tools for studying drug transporters and their impact on pharmacokinetics and cancer drug resistance.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cell Biology

Background:

  • Caco-2 cells are a human intestinal model crucial for studying drug absorption.
  • Breast cancer resistance protein (BCRP, ABCG2) and P-glycoprotein (P-gp, ABCB1) are key efflux transporters impacting drug pharmacokinetics.
  • BCRP overexpression in cancer can lead to chemotherapeutic drug resistance.

Purpose of the Study:

  • To engineer and characterize Caco-2 cell clones with stable knockdown of BCRP expression.
  • To develop a reliable cellular model for investigating BCRP's role in drug transport and resistance.
  • To facilitate the identification of BCRP substrates and inhibitors.

Main Methods:

  • Lentiviral vector-based short hairpin RNA (shRNA) was used to stably transduce Caco-2 cells.
  • BCRP expression was quantified using qPCR, Western blotting, and immunofluorescence microscopy.
  • Bidirectional transport assays with estrone-3-sulfate (E3S) and pheophorbide A (PhA) were performed.

Main Results:

  • Five stable BCRP knockdown Caco-2 cell clones were generated, with up to 97% mRNA silencing in clone D.
  • Gene silencing was stable for at least 25 passages, with significant protein reduction observed.
  • Knockdown resulted in a reduced efflux ratio for E3S and PhA, confirming functional BCRP inhibition.

Conclusions:

  • Engineered Caco-2 cell clones with stable BCRP knockdown provide a valuable tool for drug transport studies.
  • Clone D is particularly useful for P-gp substrate/inhibitor identification without BCRP interference.
  • These cell lines aid in understanding BCRP's role in drug absorption and cancer resistance.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...